Oncology Institute, Inc. Annual Nonoperating Income (Expense) in USD from 2020 to 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Oncology Institute, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2020 to 2024.
  • Oncology Institute, Inc. Nonoperating Income (Expense) for the quarter ending December 31, 2024 was -$1.25M, a 66.9% increase year-over-year.
  • Oncology Institute, Inc. Nonoperating Income (Expense) for the twelve months ending December 31, 2024 was -$4.55M, a 25.3% increase year-over-year.
  • Oncology Institute, Inc. annual Nonoperating Income (Expense) for 2024 was -$4.55M, a 25.3% increase from 2023.
  • Oncology Institute, Inc. annual Nonoperating Income (Expense) for 2023 was -$6.09M, a 107% decline from 2022.
  • Oncology Institute, Inc. annual Nonoperating Income (Expense) for 2022 was $81.9M, a 139% increase from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$4.55M +$1.54M +25.3% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-26
2023 -$6.09M -$87.9M -107% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-26
2022 $81.9M +$47.6M +139% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $34.3M +$40.9M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 -$6.62M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.